Open AccessOsteopontin can act as an effector for a germline mutation of BRCA1 in malignant transformation of breast cancer‐related cells
Author(s) -
ElTanani Mohamed K.,
Yuen HiuFung,
Shi Zhanzhong,
PlattHiggins Angela,
Buckley Niamh E.,
Mullan Paul B.,
Harkin Denis Paul,
Johnston Patrick G.,
Rudland Philip S.
Publication year - 2010
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/j.1349-7006.2010.01561.x
Subject(s) - osteopontin , cancer research , metastasis , breast cancer , cancer , biology , metastatic breast cancer , cancer cell , immunology , genetics
Breast cancer‐associated 1 (BRCA1) plays an important role in breast cancer initiation and progression through its functions in the cell cycle and DNA repair processes; however, its role in metastatic development in human breast cancer is still poorly understood. We have previously shown that osteopontin (OPN) expression was suppressed by wild‐type BRCA1 (Wt.BRCA1) and that a natural mutant allele of BRCA1 (Mut.BRCA1) diminished the effect of Wt.BRCA1 on OPN in vitro . In this study, we show that while Wt.BRCA1 suppresses OPN‐induced metastasis in a rat syngeneic system, Mut.BRCA1 enhances the development of metastasis through OPN, suggesting that OPN and BRCA1 work closely to regulate metastatic development in the rat. To test whether these findings are relevant to human breast cancer, we have investigated the relationship between BRCA1, OPN, and metastatic properties in human breast cancer‐related cells. Using western blot analysis, we show that Wt.BRCA1 suppresses, while Mut.BRCA1 enhances, OPN protein expression; and in parallel that Wt.BRCA1 suppresses, while Mut.BRCA1 enhances, OPN‐mediated in vitro properties associated with the metastatic state in both MCF‐7 and MDA MB435s cells. Overall, these results suggest that Mut.BRCA1 can elicit some of the changes involved in metastatic progression in human breast cancer via the overexpression of OPN. ( Cancer Sci 2010)